menu
    • menu

    Company profile for Exicure

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary spherical nucleic acid (SNA™) architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address inflammatory diseases, genetic disorders and oncology. Exicure is based o...
    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary spherical nucleic acid (SNA™) architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address inflammatory diseases, genetic disorders and oncology. Exicure is based outside of Chicago, IL.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ExicureUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8045 Lamon Avenue Suite 410 Skokie, IL 60077
    Telephone
    Telephone
    847.673.1700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.exicuretx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/exicure
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/exicure?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exicure Reveals Fast Stem Cell Mobilization In Multiple Myeloma
    Exicure Reveals Fast Stem Cell Mobilization In Multiple Myeloma

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232820/33289/en/Exicure-Announces-Publication-in-Annals-of-Hematology-Highlighting-Rapid-Stem-Cell-Mobilization-with-Burixafor-in-Patients-with-Multiple-Myeloma-and-Lymphoma-Undergoing-Transplant.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    Exicure Presents Burixafor Phase 2 Data at 2026 Tandem Meetings
    Exicure Presents Burixafor Phase 2 Data at 2026 Tandem Meetings

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3222636/33289/en/Exicure-to-Present-Data-from-Burixafor-Phase-2-Trial-at-the-2026-Tandem-Meetings.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    Exicure Scores In Phase 2 Multiple Myeloma Program
    Exicure Scores In Phase 2 Multiple Myeloma Program

    09 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ash-exicure-rebounds-phase-2-win-90-blood-cell-mobilization-myeloma

    FIERCE BIOTECH
    09 Dec 2025
    Share Share
    Exicure Unveils Positive Phase 2 Results For Burixafor
    Exicure Unveils Positive Phase 2 Results For Burixafor

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201986/33289/en/Exicure-Presents-Positive-Topline-Phase-2-Data-for-Burixafor-in-Multiple-Myeloma-at-2025-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Exicure Reports Third Quarter 2025 Financial Results
    Exicure Reports Third Quarter 2025 Financial Results

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183943/33289/en/Exicure-Inc-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Burixafor Clinical Data Presented Orally at 2025 ASH Meet
    Burixafor Clinical Data Presented Orally at 2025 ASH Meet

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179373/33289/en/New-Burixafor-Clinical-Data-to-be-Presented-as-an-Oral-Presentation-at-the-2025-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search